Assessment of Residual Myocardial Viability Following Streptokinase Thrombolysis in ST-Segment Elevation Myocardial Infarction Using Nitrate-Enhanced Tc-99m Sestamibi SPECT: A Cross-Sectional Study

dc.contributor.authorFawad, Ahmad
dc.contributor.authorIlyas, Saadia
dc.contributor.authorDurrani, Tayyab
dc.contributor.authorMehmood, Hamid
dc.contributor.authorAbdullah, Abdullah
dc.contributor.authorIlyas, Mohammad Saad
dc.contributor.authorUllah, Saad
dc.date.accessioned2026-09-05T09:17:58Z
dc.date.copyright2026
dc.date.issued2026-05-01
dc.description.abstractObjectives: Nitrate-enhanced myocardial perfusion imaging using technetium-99m methoxy-isobutyl-isonitrile (Tc-99m MIBI) has been shown to improve detection of viable but dysfunctional myocardium. Aim of this study was to evaluate residual myocardial viability in patients with ST-segment elevation myocardial infarction (STEMI) after successful thrombolysis with streptokinase using nitrate-enhanced Tc-99m sestamibi single-photon emission computed tomography (SPECT). Methodology: This descriptive cross-sectional study was conducted at the Department of Cardiology and the Department of Nuclear Medicine and Molecular Imaging, Northwest General Hospital & Research Center, Peshawar. A total of 62 patients aged >16 years with STEMI who underwent successful thrombolysis with streptokinase were included. Myocardial viability was assessed using a one-day nitrate-enhanced Tc-99m sestamibi SPECT protocol. Viability was defined as ≥50% tracer uptake in affected myocardial segments. Results: The mean age of participants was 53.8 ± 12.9 years, with a predominance of males (80.64%). Mean myocardial viability was 66.9 ± 29.17% in the left anterior descending (LAD) territory, 88.9 ± 14.87% in the left circumflex (LCX) territory, and 76.6 ± 30.99% in the right coronary artery (RCA) territory. When stratified by infarct location, anterior wall MI showed LAD viability of 61.4 ± 27.92%, lateral wall MI showed LCX viability of 75.6 ± 12.5%, and inferior wall MI showed comparatively lower RCA viability of 41.6 ± 32.08%. Conclusion: Nitrate-enhanced Tc-99m sestamibi SPECT imaging demonstrated substantial residual myocardial viability in patients with STEMI following successful streptokinase thrombolysis. These findings highlight its clinical utility in resource-limited settings for identifying viable myocardium and guiding subsequent management decisions.
dc.format.extentpp. 423-429
dc.identifier.citationPakistan Heart Journal; Vol. 59 No. 2 (2026), pp. 423-429
dc.identifier.doi10.47144/phj.v59i2.3110
dc.identifier.urihttps://pakheartjournal.com/index.php/pk/article/view/3110
dc.identifier.urihttps://ds.pakheartjournal.com/handle/phj/1026
dc.language.isoen
dc.publisherPakistan Heart Journal
dc.relation.ispartofseriesPakistan Heart Journal; Vol. 59 No. 2 (2026)
dc.rights.holderPakistan Heart Journal
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0
dc.titleAssessment of Residual Myocardial Viability Following Streptokinase Thrombolysis in ST-Segment Elevation Myocardial Infarction Using Nitrate-Enhanced Tc-99m Sestamibi SPECT: A Cross-Sectional Study
dc.typeArticle
person.identifier.orcidhttps://orcid.org/0000-0001-8572-6908
person.identifier.orcidhttps://orcid.org/0009-0002-0078-2199
person.identifier.orcidhttps://orcid.org/0009-0003-0891-6662
person.identifier.orcidhttps://orcid.org/0009-0004-7655-2984
person.identifier.orcidhttps://orcid.org/0009-0000-4027-9163
person.identifier.orcidhttps://orcid.org/0009-0005-4025-4325

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
3110-1-23253-1-10-20260501.pdf
Size:
600.44 KB
Format:
Adobe Portable Document Format

Collections